Canine epilepsy is a common neurological disorder with significant welfare implications for affected dogs, and optimal management balances seizure control with medication side effects and quality of life.
Canine epilepsy welfare involves managing both the direct welfare harm of seizures and the indirect welfare costs of lifelong medication. Generalized tonic-clonic seizures cause significant acute suffering, and frequent seizures without control cause cumulative neurological damage. The post-ictal period, during which dogs may be confused, distressed, or temporarily blind, adds to the welfare burden. However, with appropriate medication, many epileptic dogs achieve good seizure control and maintain excellent quality of life. The key welfare challenges are recognizing medication side effects that affect quality of life, monitoring for the liver toxicity associated with phenobarbital, and making difficult decisions about euthanasia when seizure frequency and medication burden together compromise welfare beyond acceptable levels.